However, our present study provides further evidence that HMGB1 participates in the pathogenesis of psoriasis, which may exert its regulatory effect on Th17 cell differentiation and IL‐17A production by IL‐23 and TLR4 signaling pathways to amplify its inflammatory effects. Here, IL17A is linked to psoriasis.